for the Period Ended 30 November 2024
| Company Information - 3 | |
| Report of the Directors - 4 | |
| Income and Expenditure Account - 5 | |
| Balance sheet - 6 | |
| Additional notes - 8 | |
| Balance sheet notes - 11 |
for the Period Ended 30 November 2024
| Director: |
|
|
| Secretary: |
|
|
| Registered office: |
|
|
| Company Registration Number: |
|
|
The directors present their report with the financial statements of the company for the period ended 30 November 2024
Principal Activities
Directors
The directors shown below have held office during the whole of the period from 01 December 2023 to 30 November 2024
Secretary
This report was approved by the board of directors on
And Signed On Behalf Of The Board By:
Name:
Status: Director
for the Period Ended 30 November 2024
Notes |
2024 £ |
2023 £ |
|
|---|---|---|---|
| Turnover |
|
|
|
| Cost of sales |
(
|
(
|
|
| Gross surplus or (deficit) |
|
|
|
| Income from coronavirus (COVID-19) business support grants | 0 | 0 | |
| Distribution Costs |
(
|
(
|
|
| Administrative Expenses |
(
|
(
|
|
| Other operating income |
|
|
|
| Operating surplus or (deficit) |
|
|
|
| Interest Receivable and Similar Income |
|
|
|
| Interest Payable and Similar Charges |
(
|
(
|
|
| Surplus or (deficit) before tax |
|
|
|
| Tax on surplus |
(
|
(
|
|
| Surplus or (deficit) for the period |
|
|
The notes form part of these financial statements
As at
Notes |
2024 £ |
2023 £ |
|
|---|---|---|---|
| Fixed assets | |||
| Tangible assets: | 4 |
|
|
| Total fixed assets: |
|
|
|
| Current assets | |||
| Stocks: |
|
|
|
| Debtors: | 5 |
|
|
| Cash at bank and in hand: |
|
||
| Total current assets: |
|
|
|
| Creditors: amounts falling due within one year: | 6 |
( |
( |
| Net current assets (liabilities): |
( |
( |
|
| Total assets less current liabilities: |
( |
|
|
| Creditors: amounts falling due after more than one year: | 7 |
( |
( |
| Total net assets (liabilities): |
( |
( |
The notes form part of these financial statements
As at 30 November 2024
Notes |
2024 £ |
2023 £ |
|
|---|---|---|---|
| Reserves | |||
| Income and expenditure account |
( |
( |
|
| Members funds |
( |
( |
This report was approved by the board of directors on
And Signed On Behalf Of The Board By:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 November 2024
Basis of measurement and preparation
for the Period Ended 30 November 2024
2024 |
2023 |
|
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 30 November 2024
for the Period Ended 30 November 2024
| Fixtures & fittings | Office equipment | Total | |
|---|---|---|---|
| Cost | £ | £ | £ |
| At 01 December 2023 |
|
|
|
| Additions | - | - | - |
| Disposals | - | - | - |
| Revaluations | - | - | - |
| Transfers | - | - | - |
| At 30 November 2024 |
|
|
|
| Depreciation | |||
| At 01 December 2023 |
|
|
|
| Charge for year |
|
|
|
| On disposals | - | - | - |
| Other adjustments | - | - | - |
| At 30 November 2024 |
|
|
|
| Net book value | |||
| At 30 November 2024 |
|
|
|
| At 30 November 2023 |
|
|
|
for the Period Ended 30 November 2024
2024 £ |
2023 £ |
|
|---|---|---|
| Trade debtors |
|
|
| Other debtors |
|
|
| Total |
|
|
late 2021 NHS moved from paper to electronic payments however the transitional period was an headache whereby there were months where we was massively underpaid, hence the big outstanding balance owed 22/23.
for the Period Ended 30 November 2024
2024 £ |
2023 £ |
|
|---|---|---|
| Bank loans and overdrafts |
|
|
| Amounts due under finance leases and hire purchase contracts |
|
|
| Trade creditors |
|
|
| Other creditors |
|
|
| Total |
|
|
various loans from banks and credit companies.
for the Period Ended 30 November 2024
2024 £ |
2023 £ |
|
|---|---|---|
| Bank loans and overdrafts |
|
|
| Other creditors |
|
|
| Total |
|
|